Morning Market Gainers

jumped 47.23% to $6.64 on positive studies reported on Anisina ability to kill melanoma cells.

shares rose 19.78% to $7.20 after the company announced a Fast Track Designation for Cabaletta in Oculopharyngeal Muscular Dystrophy by the FDA.

shares jumped 12.28% to $3.20 after the company reported that it has been granted a Fast Track Designation by the FDA for advanced renal cell carcinoma.

surged 11.61% to $50.94 after the company reported upbeat Q4 results.

shares gained 6.96% to $13.53 after the company reported upbeat earnings for the fourth quarter and lifted its dividend.

climbed 5.99% to $3.01 after the company reported that it has been granted wi-fi concession right on ordinary trains operated by Shanghai Railway Bureau.

shares surged 5.52% to $10.26 after jumping 7.05% on Wednesday.

shares climbed 5.42% to $26.52 after the company reported an order from the City of London for 178 AXON body cameras.

shares rose 3.51% to $26.91 as the company reported that it has received a FDA Breakthrough Therapy Designation for Viaskin Peanut for the treatment of peanut allergy in children.

shares gained 3.47% to $22.34 after the company announced a $400 million special dividend.

shares rose 2.11% to $89.53 after the company reported stronger-than-expected earnings for the second quarter. However, the company's sales missed analysts' estimates.

gained 2.02% to $2.28 after Jefferies announced its plans to acquire FXCM's institutional foreign exchange brokerage unit.